ARCHIVES

Funding and Direction of IL-2/LAK Trials Questioned By DCT Board

This article is from The Cancer Letter archive.

Vol. 15 No. 09 | March 3, 1989

Download PDF Visit The Full Archive

Related Articles

CMS Issues Coverage Decision For Provenge in Prostate Cancer

July 29, 2011

NCI RFPs Available. RFAs Available. Program Announcements.

January 14, 2000

NCI Hits Grant Targets, But Labs Feel The Pain Of Budget Cuts, Director Says.

November 23, 2007

Recommendations For Adjuvant Therapy In Breast Cancer

September 20, 1985

NCI Programs: Institute Partners With Two Groups On Psychosocial Issues

May 16, 1997

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013